HeartFlow, Inc. is a medical technology company specializing in precision heart care through advanced AI-powered software solutions. It transforms coronary computed tomography angiography (CCTA) scans into detailed 3D models of patients' coronary arteries, enabling non-invasive assessment of coronary artery disease (CAD). Key products include Roadmap Analysis for efficient CAD detection, FFRCT Analysis to evaluate blood flow and revascularization needs, and Plaque Analysis to quantify and characterize plaque for risk assessment and disease management. The integrated HeartFlow One platform supports clinicians in identifying, deciding, and managing CAD, optimizing patient care pathways with personalized insights. HeartFlow also provides comprehensive support services, including clinical, operational, technical, and financial resources to help institutions build scalable CCTA programs. Headquartered in Redwood City, California, the company plays a pivotal role in advancing proactive, patient-centered coronary care by empowering healthcare providers with innovative tools to detect, understand, and treat CAD effectively.